Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000935847-98-000016
Filing Date
1998-06-04
Accepted
1998-06-04 00:00:00
Documents
1
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SC 13D 4195
  Complete submission text file 0000935847-98-000016.txt   6051
Mailing Address 1780 ROUTE 106 MUTTONTOWN NY 11791
Business Address C/O JANSSEN MEYERS ASSOCIATION 17 STATE STREET 19TH FLOOR NEW YORK NY 1004 2127424200
JANSSEN PETER (Filed by) CIK: 0000935847 (see all company filings)

 

Mailing Address 9000 HARRY HINES BLVD DALLAS TX 75235
Business Address 9000 HARRY HINES BLVD STE 330 DALLAS TX 75235 2143532922
CYTOCLONAL PHARMACEUTICS INC /DE (Subject) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51671 | Film No.: 98642541
SIC: 2834 Pharmaceutical Preparations